Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
National Tissue Centre (NTC) is a leading European biotechnology company based in Brno, Czech Republic, specializing in the development and manufacture of advanced therapy medicinal products (ATMPs). Established as a joint venture between the Czech Ministry of Health and PrimeCell Advanced Therapy, the company operates state-of-the-art cleanroom facilities for tissue engineering and cell-based therapies. Its portfolio includes commercial products for cartilage repair (Chondrograft) and chronic wound healing (Amnioderm), as well as services in cord blood and tissue banking. NTC is a key player in the regional life sciences ecosystem, collaborating with academic institutions and hospitals to translate regenerative medicine research into clinical applications.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on National Tissue Centre.